Medicine
Fibroblast Growth Factor 21 Resistance and Metabolic Dysfunction-Associated Steatotic Liver Disease.
Mateo Chvatal-Medina, A. Post, R. Dullaart
Abstract
Abstract is not available.
Citation format
CHVATAL-MEDINA, Mateo; POST, A.; DULLAART, R. Fibroblast growth factor 21 resistance and metabolic dysfunction-associated steatotic liver disease. Metabolic Syndrome and Related Disorders, 2026, 24 5(5): 179–182.